icon-folder.gif   Conference Reports for NATAP  
 
  IDSA
ID Week 2026
October 21-24
Washington, DC

Back grey_arrow_rt.gif
 
 
 
Real-World Virologic Effectiveness Outcomes With Long-Acting Cabotegravir Plus Rilpivirine in People Who Are Treatment-Experienced With Viremia: A Systematic Literature Review and Meta-Analysis
 

 
 
  IDSA 2026 October 21-23 Wash DC
 
Monica Gandhi,1 Romain Palich,2 Inês Augusto,3 Ian Jacob,4 Patricia de los Rios,5 Kimberley Brown,5 John Houghton,6 Rokas Lukaukis,6 Bryn Jones4 1Division of HIV, ID, and Global Medicine, University of California, San Francisco, CA, USA; 2Paris Cité University, AP-HP, Hôtel-Dieu Hospital, Paris, France; 3ViiV Healthcare, Algés, Portugal; 4ViiV Healthcare, London, UK; 5ViiV Healthcare, Durham, NC, USA; 6HEOR Ltd, Cardiff, UK
 

1023261copy

1023262copy

1023263copy

1023264copy

1023265copy

1023266copy

1023267copy

1023268copy